Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof Susana Banerjee, including the following topics:

• Overview of the biology and treatment of low-grade serous ovarian cancer (0:00)
• Mechanism of action of avutometinib/defactinib (10:16)
• RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian cancer (14:32)
• Ongoing clinical trials in low-grade serous ovarian cancer (27:57)

CME information and select publications